AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

ANHYDROUS GLUCOSE

6 registrations across 4 African markets— 3 active

Markets with ANHYDROUS GLUCOSE

🇲🇼Malawi
2 registrations
0 active
🇿🇲Zambia
2 registrations
2 active
🇹🇿Tanzania
1 registration
1 active
🇿🇦South Africa
1 registration
0 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
5D
Solution For Infusion
🇿🇲ZambiaKAIRUKI PHARMACEUTICALS INDUSTRY LIMITEDactiveJun 2030
Glucose Intravenous infusion (5D)
Solution for Injection
🇿🇲ZambiaClaris Life Sciences Ltd+ IndiaactiveJul 2029
D50_IV 50%W/V INFUSION
INFUSION
🇲🇼Malawi—expiredMar 2025
D5 5%W/V IV INFUSION
IV INFUSION
🇲🇼Malawi—expiredMar 2025
ELECTRONA🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedNov 2022
D-40 (Glucose Injection BP)
Solution for injection
🇹🇿TanzaniaAMANTA HEALTHCARE LTDactive—

ANHYDROUS GLUCOSE in Africa — Regulatory Overview

ANHYDROUS GLUCOSE is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Zambia, Tanzania, South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 6 registrations, 3 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.